Candriam S.C.A. - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 229 filers reported holding AMICUS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,039,169
-19.2%
578,879
-16.6%
0.05%
-20.6%
Q2 2023$8,715,120
+23.0%
693,8790.0%0.06%
+28.6%
Q1 2023$7,082,809
-16.4%
693,8790.0%0.05%
-14.0%
Q4 2022$8,471,866
+21.3%
693,879
+3.7%
0.06%
+16.3%
Q3 2022$6,983,000
-22.5%
668,879
-20.3%
0.05%
-33.8%
Q2 2022$9,009,000
-34.0%
838,879
+36.4%
0.07%
-35.1%
Q1 2021$13,643,000
-3.9%
615,1240.0%0.11%
+1.8%
Q4 2020$14,204,000
+30.4%
615,124
-20.3%
0.11%
+9.8%
Q3 2020$10,894,000
-2.6%
771,588
+4.0%
0.10%
-13.6%
Q2 2020$11,184,000
+26.4%
741,588
-20.2%
0.12%
+20.4%
Q1 2020$8,850,000
-2.2%
929,5000.0%0.10%
+1.0%
Q4 2019$9,053,000
+15.6%
929,500
-4.8%
0.10%
-6.7%
Q3 2019$7,828,000
-28.9%
976,000
+10.2%
0.10%
-24.1%
Q2 2019$11,009,000
+10.0%
886,000
+20.4%
0.14%
+7.0%
Q1 2019$10,010,000
+75.3%
736,000
+23.5%
0.13%
+45.5%
Q4 2018$5,709,000
-11.1%
596,000
+12.2%
0.09%
+3.5%
Q3 2018$6,420,000
-10.8%
531,000
+15.2%
0.08%
-25.4%
Q2 2018$7,201,000
+3.0%
461,000
-0.9%
0.11%
-4.2%
Q1 2018$6,994,000
-10.1%
465,000
-14.0%
0.12%
-11.9%
Q4 2017$7,776,000
+6.9%
540,400
+12.0%
0.14%
+6.3%
Q3 2017$7,275,000
-9.3%
482,400
-39.5%
0.13%
-15.9%
Q2 2017$8,025,000
+54.8%
796,900
+9.6%
0.15%
+51.0%
Q1 2017$5,183,000
+21.0%
726,900
-15.7%
0.10%
+2.0%
Q4 2016$4,283,000
-41.4%
861,900
-12.7%
0.10%
-44.3%
Q3 2016$7,303,000
+88.4%
986,900
+39.0%
0.18%
+74.3%
Q2 2016$3,876,000
-25.6%
709,900
+14.5%
0.10%
-22.3%
Q1 2016$5,210,000
-29.7%
619,900
-18.9%
0.13%
-34.3%
Q4 2015$7,411,000
-43.9%
764,000
-19.1%
0.20%
-38.9%
Q3 2015$13,207,000
-20.2%
944,000
-19.3%
0.32%
-6.1%
Q2 2015$16,555,000
+12.7%
1,170,000
-13.3%
0.34%
+16.6%
Q1 2015$14,691,000
+154.1%
1,350,000
+94.2%
0.30%
+144.6%
Q4 2014$5,782,000695,0000.12%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 10,114,043$116,817,0007.46%
Parametrica Management Ltd 597,279$6,899,0006.86%
Redmile Group, LLC 22,716,086$262,371,0005.96%
Perceptive Advisors 53,118,886$613,524,0004.73%
Asymmetry Capital Management, L.P. 716,709$8,278,0004.39%
CM Management, LLC 450,000$5,198,0003.93%
Avoro Capital Advisors LLC 18,500,000$213,675,0003.64%
Kynam Capital Management, LP 573,699$6,626,0003.54%
SECTORAL ASSET MANAGEMENT INC 1,242,882$14,355,0002.16%
Ghost Tree Capital, LLC 500,000$5,775,0002.07%
View complete list of AMICUS THERAPEUTICS INC shareholders